Press Release

AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies    RADNOR, PA…

Radnor, PA — May 29, 2024 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

RADNOR, PA – May 21, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. (Nasdaq: CERT), a…

PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

PRINCETON, N.J.— April 9, 2024-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

Provides Full Year 2024 Financial Guidance PRINCETON, N.J.— February 29, 2024-- Certara, Inc. (Nasdaq: CERT), a…

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex…